
Nalu Medical
A range of medical devices.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
* | $65.0m Valuation: $520m | Series E | |
Total Funding | 000k |
Related Content
NaluMed is a groundbreaking startup that operates in the medical technology sector, specifically in the field of neurology. The company has developed a revolutionary product known as the Nalu Neurostimulation System, which is designed to manage intractable chronic pain. This system uses gentle electrical impulses to interrupt pain signals before they reach the brain, offering a drug-free therapy alternative for patients.
The company's primary clients are patients suffering from chronic pain, and the product is administered with the help of medical professionals. The Nalu Neurostimulation System is a small device implanted under the skin, which is up to 27 times smaller than the largest commercially available Inplantable Pulse Generator (IPG). This small size minimizes the chances of the device being visible beneath the skin.
NaluMed's business model is centered around the sale of these devices, which are designed to be easily upgradeable to the latest therapies without the need for surgery. This feature not only provides a long-term solution for patients but also eliminates the need for battery replacement surgeries, thereby reducing the overall cost and inconvenience for the patient.
The company has been recognized for its innovative technology, winning the 2021 Medical Design Excellence Award and the MedTech Visionaries Award for Best MedTech Company and Best Medical Device in the field of neurology.
Keywords: NaluMed, Neurostimulation System, Chronic Pain Management, Medical Technology, Neurology, Drug-free Therapy, Implantable Device, Medical Design Excellence, MedTech Visionaries Award, Battery-free Device.